M

Monte Rosa Therapeutics

Develops targeted protein degraders for therapy

Director Regulatory Affairs - Global Regulatory Strategy

Regulatory & Quality (Life Sciences)Posted on Nov 5
Full-timeBoston, MA, USA$180k - $245kIn-person

About the Job

Requirements

  • A minimum of 12 years of experience in global regulatory affairs within the pharmaceutical or biotechnology industry is required.
  • Global regulatory strategy experience is required, including direct involvement with United States, European Union, and international regulatory submissions and strategy.
  • Demonstrated experience leading health authority meetings, including with the FDA, EMA, and PMDA, is required.
  • Strong understanding of regulatory requirements and industry guidelines, including FDA, EMA, and ICH, is required.

Responsibilities

  • Develop and lead global regulatory strategies for assigned programs from early development through approval and lifecycle management.
  • Ensure regulatory strategies align with corporate goals and evolving regulatory expectations.
  • Lead the preparation, submission, and maintenance of regulatory applications, including INDs, CTAs, marketing applications, Annual Reports, Orphan Drug Designation, Requests for Fast Track, and other regulatory documents.
  • Lead regulatory interactions and meetings with global health authorities, including FDA, EMA, and other major agencies.
  • Ensure compliance with global regulatory requirements and guidelines, including FDA, EMA, and other regulatory authorities.
  • Represent Regulatory on cross-functional product teams and provide strategic regulatory guidance and support to achieve product development objectives.
  • Collaborate with internal and external stakeholders, and manage and oversee third-party vendors and consultants to ensure high-quality submissions and successful execution of regulatory strategies.
  • Maintain regulatory files and databases, track regulatory commitments, and support the development of processes, standard operating procedures, work instructions, and other controlled documents.

Desired Qualifications

  • A bachelor's degree in health sciences or a related field, or an advanced degree, is preferred.
  • Experience in immunology or cardiovascular therapeutic areas is preferred.
  • CMC regulatory experience or strong working knowledge is a plus.

About the Company

Monte Rosa Therapeutics

Develops targeted protein degraders for therapy

Monte Rosa Therapeutics develops molecular glue degraders (MGDs) to treat cancer and autoimmune/inflammatory diseases using its QuEEN discovery engine, a platform that fuses AI-guided chemistry, proteomics, and structural biology to design MGDs. MGDs work by bringing a target protein together with an E3 ligase, tagging the protein for destruction by the cell's proteasome rather than just inhibiting it. The company distinguishes itself with the QuEEN platform, partnerships with Roche and Novartis for joint development and funding, and a portfolio that includes MRT-2359, MRT-6160, and MRT-8102 as clinical-stage programs. Its goal is to discover, develop, and commercialize MGDs, grow its pipeline, and create value through collaborations, upfront payments, milestones, and royalties while delivering treatments for patients with serious diseases.

Company size
201-500
Company stage
IPO
Headquarters
Boston, MA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Monte Rosa Therapeutics

See more jobs